News & Updates

Back to All News

Innovative approach to ovarian cancer treatment unveiled by biomedical scientists at the Lankenau Institute for Medical Research

March 28, 2016 Research News
The ground-breaking study by Janet Sawicki, PhD, and her colleagues at the Main Line Health’s Lankenau Institute for Medical Research (LIMR)  is the first to show the potential of targeted reduction of a specific protein in ovarian tumors, but not in healthy cells, following systemic administration.

See more from BioSpace and Philadelphia Business Journal.